The Council for Responsible Nutrition on Thursday welcomed the passage of the Designer Anabolic Steroid Control Act of 2014, a measure that will protect consumers from potentially dangerous anabolic steroids falsely marketed as dietary supplements.
With the youngest of the baby boomers having turned 50 this year, adult incontinence is proving to be a high-traffic, high-frequency category with a decent amount of margin, at least in the drug channel. According to Competitive Promotion Report, the drug channel enjoys a 35% margin in this category on average.
Bomuca is in the process of launching a Hispanic-centric line of supplements and recently gained distribution through Walgreens, the supplier reported. DSN sat down with Oliver Pegueros, director of operations and business development at Bomuca, to get a sense of what the new supplement line is all about.
Australian Dream is one of those hot external analgesic products that has been growing by greater than 20% across all channels. Drug Store News had an opportunity to dig a little deeper regarding the Nature s Health Connection s Australian Dream product with David Biernbaum of David Biernbaum and Assoc., who represents the product.
External analgesics is a category replete with growth brands with a base of $497.8 million across total U.S. multi-outlets, and more than 8.1% in growth for the 52 weeks ended Sept. 7, according to IRI data.
Between 2013 and 2020, there is the possibility of more than $12 billion in healthcare cost savings if women older than 55 years were to take with calcium and vitamin D supplements, the Council for Responsible Nutrition revealed in a release issued Tuesday.